XLO NASDAQ
Xilio Therapeutics, Inc.
1W: -0.3%
1M: +1.9%
3M: -4.6%
YTD: +1241.4%
1Y: +982.1%
3Y: +327.0%
$9.01
+0.10 (+1.12%)
Weekly Expected Move ±2.0%
$9
$9
$9
$9
$9
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$64M
Revenue
+327.3% YoY
$-22M
Net Income
+61.2% YoY
$-61M
Free Cash Flow
-345.1% YoY
100.0%
Gross Margin
-18.7%
Op. Margin
-34.1%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-55.0%
ROA-15.2%
ROIC43.1%
Valuation
P/E-6.0
P/B2.4
EV/EBITDA-2.7
Leverage
Debt/Equity0.09
Current Ratio4.25
Interest Cov.0.0x
Quality Scores
Piotroski F6/9
Altman Z-1.77
Beneish M-1.05